NASDAQ · OSRHW
OSR Holdings, Inc.
Healthcare · Biotechnology
$0.03
Down-$0.00 (-1.00%)
Updated Oct 11, 2026, 12:27 AM
SID Score
2.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.28M
- P/E ratio
- -0.84
- Dividend yield
- 0.00%
- 52-week range
- $0.03 – $0.10
- Volume
- 30.12K
- Avg. volume
- 44.73K
Price performance · OSRHW
OSRHW price history
1M range · 0 trading sessions · Daily adjusted prices
OSRHW does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest OSRHW news
The latest Smart Investors Daily articles mentioning OSRHW.
Stock researchCompany · Overview
Company
Market Activity
Research & News
OSRHW research
Overview
Company profile and research snapshot.
Company profile
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
